In Vitro Activity of Cefepime-Enmetazobactam against Gram-Negative Isolates Collected from U.S. and European Hospitals during 2014–2015

Enmetazobactam, formerly AAI101, is a novel penicillanic acid sulfone extended-spectrum β-lactamase (ESBL) inhibitor. The combination of enmetazobactam with cefepime has entered clinical trials to assess safety and efficacy in patients with complicated urinary tract infections. Here, the in vitro ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Morrissey, Ian, Magnet, Sophie, Hawser, Stephen, Shapiro, Stuart, Knechtle, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2019
Materias:
Epidemiology and Surveillance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591593/
https://www.ncbi.nlm.nih.gov/pubmed/30988152
http://dx.doi.org/10.1128/AAC.00514-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591593/
https://www.ncbi.nlm.nih.gov/pubmed/30988152
http://dx.doi.org/10.1128/AAC.00514-19

Ejemplares similares